{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:01:01Z","timestamp":1740139261542,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["D10I1282"],"award-info":[{"award-number":["D10I1282"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10930-019-09867-y","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T07:02:36Z","timestamp":1569654156000},"page":"693-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression and Characterization of Human Vascular Endothelial Growth Factor Produced in SiHa Cells Transduced with Adenoviral Vector"],"prefix":"10.1007","volume":"38","author":[{"given":"N. C.","family":"Parra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mansilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Aedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Vispo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. E.","family":"Gonz\u00e1lez-Horta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gonz\u00e1lez-Chavarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-8674","authenticated-orcid":false,"given":"O.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"issue":"14","key":"9867_CR1","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1073\/pnas.94.14.7192","volume":"94","author":"YA Muller","year":"1997","unstructured":"Muller YA, Li B, Christinger HW, Wells JA, Cunningham BC, de Vos AM (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA 94(14):7192\u20137197","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"9867_CR2","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","volume":"12","author":"M Kowanetz","year":"2006","unstructured":"Kowanetz M, Ferrara N (2006) Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12(17):5018\u20135022. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-1520","journal-title":"Clin Cancer Res"},{"key":"9867_CR3","first-page":"15","volume":"55","author":"N Ferrara","year":"2000","unstructured":"Ferrara N (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15\u201335 (discussion 35\u201316)","journal-title":"Recent Prog Horm Res"},{"issue":"4935","key":"9867_CR4","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935):1306\u20131309","journal-title":"Science"},{"issue":"36","key":"9867_CR5","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","volume":"267","author":"KA Houck","year":"1992","unstructured":"Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267(36):26031\u201326037","journal-title":"J Biol Chem"},{"issue":"18","key":"9867_CR6","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","volume":"266","author":"E Tischer","year":"1991","unstructured":"Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266(18):11947\u201311954","journal-title":"J Biol Chem"},{"issue":"1","key":"9867_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2013.11.002","volume":"25","author":"P Vempati","year":"2014","unstructured":"Vempati P, Popel AS, Mac Gabhann F (2014) Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. Cytokine Growth Factor Rev 25(1):1\u201319. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.11.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"9867_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4\u201325. https:\/\/doi.org\/10.1210\/edrv.18.1.0287","journal-title":"Endocr Rev"},{"issue":"6801","key":"9867_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242\u2013248. https:\/\/doi.org\/10.1038\/35025215","journal-title":"Nature"},{"issue":"1","key":"9867_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0897.1997.tb00189.x","volume":"37","author":"DS Torry","year":"1997","unstructured":"Torry DS, Torry RJ (1997) Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 37(1):21\u201329","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"9867_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.acthis.2009.04.004","volume":"112","author":"R Demir","year":"2010","unstructured":"Demir R, Yaba A, Huppertz B (2010) Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochem 112(3):203\u2013214. https:\/\/doi.org\/10.1016\/j.acthis.2009.04.004","journal-title":"Acta Histochem"},{"issue":"3","key":"9867_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0091-3057(77)90030-2","volume":"6","author":"JR Bassett","year":"1977","unstructured":"Bassett JR, Cairncross KD (1977) Changes in the coronary vascular system following prolonged exposure to stress. Pharmacol Biochem Behav 6(3):311\u2013318","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"9867_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"AE Koch","year":"1998","unstructured":"Koch AE (1998) Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41(6):951\u2013962","journal-title":"Arthritis Rheum"},{"issue":"7","key":"9867_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/08916930903002461","volume":"42","author":"RA Chua","year":"2009","unstructured":"Chua RA, Arbiser JL (2009) The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity 42(7):574\u2013579","journal-title":"Autoimmunity"},{"issue":"1","key":"9867_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/path.2518","volume":"218","author":"JC Sluimer","year":"2009","unstructured":"Sluimer JC, Daemen MJ (2009) Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 218(1):7\u201329. https:\/\/doi.org\/10.1002\/path.2518","journal-title":"J Pathol"},{"issue":"10","key":"9867_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/nm1010-1107","volume":"16","author":"N Ferrara","year":"2010","unstructured":"Ferrara N (2010) Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nat Med 16(10):1107\u20131111. https:\/\/doi.org\/10.1038\/nm1010-1107","journal-title":"Nat Med"},{"issue":"21","key":"9867_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182\u20131186. https:\/\/doi.org\/10.1056\/NEJM197111182852108","journal-title":"N Engl J Med"},{"key":"9867_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.med.49.1.407","volume":"49","author":"BR Zetter","year":"1998","unstructured":"Zetter BR (1998) Angiogenesis and tumor metastasis. Annu Rev Med 49:407\u2013424. https:\/\/doi.org\/10.1146\/annurev.med.49.1.407","journal-title":"Annu Rev Med"},{"issue":"6 Suppl 16","key":"9867_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"J Folkman","year":"2002","unstructured":"Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15\u201318. https:\/\/doi.org\/10.1053\/sonc.2002.37263","journal-title":"Semin Oncol"},{"issue":"1","key":"9867_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82(1):4\u20136","journal-title":"J Natl Cancer Inst"},{"issue":"6398","key":"9867_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843\u2013845. https:\/\/doi.org\/10.1038\/359843a0","journal-title":"Nature"},{"issue":"5","key":"9867_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"4","key":"9867_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larrivee B (2017) Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis 20(4):409\u2013426. https:\/\/doi.org\/10.1007\/s10456-017-9562-9","journal-title":"Angiogenesis"},{"issue":"5","key":"9867_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/cgt.2016.12","volume":"23","author":"M Kazemi","year":"2016","unstructured":"Kazemi M, Carrer A, Moimas S, Zandona L, Bussani R, Casagranda B, Palmisano S, Prelazzi P, Giacca M, Zentilin L, De Manzini N, Giacca M, Zacchigna S (2016) VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. Cancer Gene Ther 23(5):125\u2013132. https:\/\/doi.org\/10.1038\/cgt.2016.12","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"9867_CR25","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26(8):859\u2013870. https:\/\/doi.org\/10.1097\/01.iae.0000242842.14624.e7","journal-title":"Retina"},{"issue":"12","key":"9867_CR26","doi-asserted-by":"publisher","first-page":"a006593","DOI":"10.1101\/cshperspect.a006593","volume":"2","author":"MW Kieran","year":"2012","unstructured":"Kieran MW, Kalluri R, Cho YJ (2012) The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harbor Perspect Med 2(12):a006593. https:\/\/doi.org\/10.1101\/cshperspect.a006593","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"9867_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081786","author":"DH Kong","year":"2017","unstructured":"Kong DH, Kim MR, Jang JH, Na HJ, Lee S (2017) A review of anti-angiogenic targets for monoclonal antibody cancer therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18081786","journal-title":"Int J Mol Sci"},{"issue":"8","key":"9867_CR28","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-12-2911","volume":"19","author":"KK Ciombor","year":"2013","unstructured":"Ciombor KK, Berlin J, Chan E (2013) Aflibercept. Clin Cancer Res 19(8):1920\u20131925. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2911","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9867_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","volume":"8","author":"JM Ebos","year":"2011","unstructured":"Ebos JM, Kerbel RS (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 8(4):210\u2013221. https:\/\/doi.org\/10.1038\/nrclinonc.2011.21","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"9867_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/14712598.2017.1333596","volume":"17","author":"J Adeghate","year":"2017","unstructured":"Adeghate J, Nurulain S, Tekes K, Feher E, Kalasz H, Adeghate E (2017) Novel biological therapies for the treatment of diabetic foot ulcers. Expert Opin Biol Ther 17(8):979\u2013987. https:\/\/doi.org\/10.1080\/14712598.2017.1333596","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"9867_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41434-018-0027-6","volume":"25","author":"R Shi","year":"2018","unstructured":"Shi R, Lian W, Han S, Cao C, Jin Y, Yuan Y, Zhao H, Li M (2018) Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats. Gene Ther 25(6):425\u2013438. https:\/\/doi.org\/10.1038\/s41434-018-0027-6","journal-title":"Gene Ther"},{"issue":"6","key":"9867_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/08977194.2018.1435532","volume":"35","author":"HY Tsui","year":"2017","unstructured":"Tsui HY, Liu YC, Yan X, Lin Y, Xu Y, Tan Q (2017) Combined effects of artificial dermis and vascular endothelial growth factor concentration gradient on wound healing in diabetic porcine model. Growth Factors 35(6):216\u2013224. https:\/\/doi.org\/10.1080\/08977194.2018.1435532","journal-title":"Growth Factors"},{"issue":"9","key":"9867_CR33","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/jid.2009.235","volume":"129","author":"T Rico","year":"2009","unstructured":"Rico T, Green J, Kirsner RS (2009) Vascular endothelial growth factor delivery via gene therapy for diabetic wounds: first steps. J Invest Dermatol 129(9):2084. https:\/\/doi.org\/10.1038\/jid.2009.235","journal-title":"J Invest Dermatol"},{"issue":"3","key":"9867_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1050-1738(01)00158-X","volume":"12","author":"ML Koransky","year":"2002","unstructured":"Koransky ML, Robbins RC, Blau HM (2002) VEGF gene delivery for treatment of ischemic cardiovascular disease. Trends Cardiovasc Med 12(3):108\u2013114","journal-title":"Trends Cardiovasc Med"},{"key":"9867_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mehy.2017.09.024","volume":"109","author":"F Qiu","year":"2017","unstructured":"Qiu F, Cao H, Wu Y (2017) A new analytical model for the changes of vascular endothelial growth factor in ischemic diseases. Med Hypotheses 109:73\u201376. https:\/\/doi.org\/10.1016\/j.mehy.2017.09.024","journal-title":"Med Hypotheses"},{"issue":"2","key":"9867_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cyto.2014.08.005","volume":"71","author":"TD Crafts","year":"2015","unstructured":"Crafts TD, Jensen AR, Blocher-Smith EC, Markel TA (2015) Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 71(2):385\u2013393. https:\/\/doi.org\/10.1016\/j.cyto.2014.08.005","journal-title":"Cytokine"},{"issue":"2","key":"9867_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/bbrc.1996.0730","volume":"222","author":"G Siemeister","year":"1996","unstructured":"Siemeister G, Schnurr B, Mohrs K, Schachtele C, Marme D, Martiny-Baron G (1996) Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun 222(2):249\u2013255. https:\/\/doi.org\/10.1006\/bbrc.1996.0730","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9867_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pep.2010.03.007","volume":"72","author":"SA Pizarro","year":"2010","unstructured":"Pizarro SA, Gunson J, Field MJ, Dinges R, Khoo S, Dalal M, Lee M, Kaleas KA, Moiseff K, Garnick S, Reilly DE, Laird MW, Schmelzer CH (2010) High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications. Protein Expr Purif 72(2):184\u2013193. https:\/\/doi.org\/10.1016\/j.pep.2010.03.007","journal-title":"Protein Expr Purif"},{"issue":"1","key":"9867_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pep.2010.08.014","volume":"76","author":"IL Lee","year":"2011","unstructured":"Lee IL, Li PS, Yu WL, Shen HH (2011) Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited. Protein Expr Purif 76(1):54\u201358. https:\/\/doi.org\/10.1016\/j.pep.2010.08.014","journal-title":"Protein Expr Purif"},{"issue":"2","key":"9867_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-4165(94)00150-v","volume":"1243","author":"S Kondo","year":"1995","unstructured":"Kondo S, Matsumoto T, Yokoyama Y, Ohmori I, Suzuki H (1995) The shortest isoform of human vascular endothelial growth factor\/vascular permeability factor (VEGF\/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochem Biophys Acta 1243(2):195\u2013202. https:\/\/doi.org\/10.1016\/0304-4165(94)00150-v","journal-title":"Biochem Biophys Acta"},{"issue":"4","key":"9867_CR41","first-page":"302","volume":"14","author":"L Ma","year":"2001","unstructured":"Ma L, Wang XN, Zhang ZQ, Chen AJ, Yao LH (2001) Expression of human vascular endothelial growth factor (VEGF165) in Pichia pastoris and its biological activity. Biomed Environ Sci 14(4):302\u2013311","journal-title":"Biomed Environ Sci"},{"issue":"2","key":"9867_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pep.2005.09.023","volume":"46","author":"GY Lee","year":"2006","unstructured":"Lee GY, Jung WW, Kang CS, Bang IS (2006) Expression and characterization of human vascular endothelial growth factor (VEGF165) in insect cells. Protein Expr Purif 46(2):503\u2013509. https:\/\/doi.org\/10.1016\/j.pep.2005.09.023","journal-title":"Protein Expr Purif"},{"issue":"1","key":"9867_CR43","first-page":"183","volume":"18","author":"SB Lee","year":"2008","unstructured":"Lee SB, Park JS, Lee S, Park J, Yu S, Kim H, Kim D, Byun TH, Baek K, Ahn YJ, Yoon J (2008) Overproduction of recombinant human VEGF (vascular endothelial growth factor) in Chinese hamster ovary cells. J Microbiol Biotechnol 18(1):183\u2013187","journal-title":"J Microbiol Biotechnol"},{"issue":"2","key":"9867_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1026466408042","volume":"16","author":"E Grabenhorst","year":"1999","unstructured":"Grabenhorst E, Schlenke P, Pohl S, Nimtz M, Conradt HS (1999) Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj J 16(2):81\u201397","journal-title":"Glycoconj J"},{"issue":"7","key":"9867_CR45","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.vaccine.2007.11.014","volume":"26","author":"O Sanchez","year":"2008","unstructured":"Sanchez O, Barrera M, Rodriguez MP, Frias MT, Figueroa NE, Naranjo P, Montesino R, Farnos O, Castell S, Venereo A, Ganges L, Borroto C, Toledo JR (2008) Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. Vaccine 26(7):988\u2013997. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.014","journal-title":"Vaccine"},{"issue":"1\u20132","key":"9867_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jbiotec.2004.06.009","volume":"114","author":"O Sanchez","year":"2004","unstructured":"Sanchez O, Toledo JR, Rodriguez MP, Castro FO (2004) Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats. J Biotechnol 114(1\u20132):89\u201397. https:\/\/doi.org\/10.1016\/j.jbiotec.2004.06.009","journal-title":"J Biotechnol"},{"issue":"5","key":"9867_CR47","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","volume":"10","author":"K Benihoud","year":"1999","unstructured":"Benihoud K, Yeh P, Perricaudet M (1999) Adenovirus vectors for gene delivery. Curr Opin Biotechnol 10(5):440\u2013447","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"9867_CR48","first-page":"153","volume":"18","author":"ZS Han","year":"2008","unstructured":"Han ZS, Li QW, Zhang ZY, Yu YS, Xiao B, Wu SY, Jiang ZL, Zhao HW, Zhao R, Li J (2008) Adenoviral vector mediates high expression levels of human lactoferrin in the milk of rabbits. J Microbiol Biotechnol 18(1):153\u2013159","journal-title":"J Microbiol Biotechnol"},{"issue":"12","key":"9867_CR49","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1128\/CVI.00416-14","volume":"21","author":"O Sanchez","year":"2014","unstructured":"Sanchez O, Barrera M, Farnos O, Parra NC, Salgado ER, Saavedra PA, Meza CD, Rivas CI, Cortez-San Martin M, Toledo JR (2014) Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats. Clin Vaccine Immunol 21(12):1628\u20131634. https:\/\/doi.org\/10.1128\/CVI.00416-14","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"9867_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/bp060187j","volume":"23","author":"B Gaillet","year":"2007","unstructured":"Gaillet B, Gilbert R, Amziani R, Guilbault C, Gadoury C, Caron AW, Mullick A, Garnier A, Massie B (2007) High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnol Prog 23(1):200\u2013209. https:\/\/doi.org\/10.1021\/bp060187j","journal-title":"Biotechnol Prog"},{"issue":"1\u20133","key":"9867_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/bf00762389","volume":"15","author":"A Garnier","year":"1994","unstructured":"Garnier A, Cote J, Nadeau I, Kamen A, Massie B (1994) Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnology 15(1\u20133):145\u2013155. https:\/\/doi.org\/10.1007\/bf00762389","journal-title":"Cytotechnology"},{"issue":"5","key":"9867_CR52","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95(5):2509\u20132514. https:\/\/doi.org\/10.1073\/pnas.95.5.2509","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5304","key":"9867_CR53","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304):1320\u20131323. https:\/\/doi.org\/10.1126\/science.275.5304.1320","journal-title":"Science"},{"issue":"6","key":"9867_CR54","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ijc.10891","volume":"103","author":"J Fuxe","year":"2003","unstructured":"Fuxe J, Liu L, Malin S, Philipson L, Collins VP, Pettersson RF (2003) Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer 103(6):723\u2013729. https:\/\/doi.org\/10.1002\/ijc.10891","journal-title":"Int J Cancer"},{"issue":"3\u20134","key":"9867_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.vetmic.2011.05.033","volume":"152","author":"AG Pose","year":"2011","unstructured":"Pose AG, Gomez JN, Sanchez AV, Redondo AV, Rodriguez ER, Segui RM, Ramos EM, Molto MP, Rodriguez ES, Cordero LR, Mallon AR, Nordelo CB (2011) Subunit influenza vaccine candidate based on CD154 fused to HAH5 increases the antibody titers and cellular immune response in chickens. Vet Microbiol 152(3\u20134):328\u2013337. https:\/\/doi.org\/10.1016\/j.vetmic.2011.05.033","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"9867_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1432-1033.1993.tb19865.x","volume":"211","author":"BL Fiebich","year":"1993","unstructured":"Fiebich BL, Jager B, Schollmann C, Weindel K, Wilting J, Kochs G, Marme D, Hug H, Weich HA (1993) Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 211(1\u20132):19\u201326","journal-title":"Eur J Biochem"},{"issue":"2","key":"9867_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/08977199209046402","volume":"7","author":"T Cohen","year":"1992","unstructured":"Cohen T, Gitay-Goren H, Neufeld G, Levi BZ (1992) High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system. Growth Factors 7(2):131\u2013138","journal-title":"Growth Factors"},{"issue":"1","key":"9867_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/prep.2001.1472","volume":"23","author":"MV Backer","year":"2001","unstructured":"Backer MV, Backer JM (2001) Functionally active VEGF fusion proteins. Protein Expr Purif 23(1):1\u20137. https:\/\/doi.org\/10.1006\/prep.2001.1472","journal-title":"Protein Expr Purif"},{"issue":"1","key":"9867_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-4838(94)00144-6","volume":"1246","author":"KP Claffey","year":"1995","unstructured":"Claffey KP, Senger DR, Spiegelman BM (1995) Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF\/VEGF. Biochem Biophys Acta 1246(1):1\u20139. https:\/\/doi.org\/10.1016\/0167-4838(94)00144-6","journal-title":"Biochem Biophys Acta"},{"issue":"7","key":"9867_CR60","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1091\/mbc.E13-07-0418","volume":"25","author":"ML Guzman-Hernandez","year":"2014","unstructured":"Guzman-Hernandez ML, Potter G, Egervari K, Kiss JZ, Balla T (2014) Secretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane. Mol Biol Cell 25(7):1061\u20131072. https:\/\/doi.org\/10.1091\/mbc.E13-07-0418","journal-title":"Mol Biol Cell"},{"issue":"3","key":"9867_CR61","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/0006-291x(92)91880-y","volume":"182","author":"D Peretz","year":"1992","unstructured":"Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G (1992) Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. Biochem Biophys Res Commun 182(3):1340\u20131347. https:\/\/doi.org\/10.1016\/0006-291x(92)91880-y","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9867_CR62","first-page":"546","volume":"74","author":"DH Walter","year":"1996","unstructured":"Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM (1996) The in vivo bioactivity of vascular endothelial growth factor\/vascular permeability factor is independent of N-linked glycosylation. Lab Invest 74(2):546\u2013556","journal-title":"Lab Invest"},{"issue":"Pt 1","key":"9867_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BA20050169","volume":"44","author":"Y Morera","year":"2006","unstructured":"Morera Y, Lamdan H, Bequet M, Ayala M, Rojas G, Munoz Y, Gavilondo JV (2006) Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S-transferase fusion protein. Biotechnol Appl Biochem 44(Pt 1):45\u201353. https:\/\/doi.org\/10.1042\/BA20050169","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"9867_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/protein\/13.1.67","volume":"13","author":"G Lindwall","year":"2000","unstructured":"Lindwall G, Chau M, Gardner SR, Kohlstaedt LA (2000) A sparse matrix approach to the solubilization of overexpressed proteins. Protein Eng 13(1):67\u201371","journal-title":"Protein Eng"},{"key":"9867_CR65","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/srep00706","volume":"2","author":"EP Hudson","year":"2012","unstructured":"Hudson EP, Uhlen M, Rockberg J (2012) Multiplex epitope mapping using bacterial surface display reveals both linear and conformational epitopes. Sci Rep 2:706. https:\/\/doi.org\/10.1038\/srep00706","journal-title":"Sci Rep"},{"issue":"10","key":"9867_CR66","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1021\/mp500160v","volume":"11","author":"J Yang","year":"2014","unstructured":"Yang J, Wang X, Fuh G, Yu L, Wakshull E, Khosraviani M, Day ES, Demeule B, Liu J, Shire SJ, Ferrara N, Yadav S (2014) Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A. Mol Pharm 11(10):3421\u20133430. https:\/\/doi.org\/10.1021\/mp500160v","journal-title":"Mol Pharm"},{"issue":"2","key":"9867_CR67","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1160\/TH03-02-0084","volume":"90","author":"L Favot","year":"2003","unstructured":"Favot L, Keravis T, Holl V, Le Bec A, Lugnier C (2003) VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thromb Haemost 90(2):334\u2013343. https:\/\/doi.org\/10.1160\/TH03-02-0084","journal-title":"Thromb Haemost"},{"issue":"1\u20132","key":"9867_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0022-1759(01)00408-2","volume":"254","author":"V Marin","year":"2001","unstructured":"Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P (2001) Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254(1\u20132):183\u2013190","journal-title":"J Immunol Methods"},{"issue":"3","key":"9867_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nprot.2007.54","volume":"2","author":"B Baudin","year":"2007","unstructured":"Baudin B, Bruneel A, Bosselut N, Vaubourdolle M (2007) A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2(3):481\u2013485. https:\/\/doi.org\/10.1038\/nprot.2007.54","journal-title":"Nat Protoc"},{"issue":"6","key":"9867_CR70","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/bjc.2014.166","volume":"111","author":"RJ Geraghty","year":"2014","unstructured":"Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, Lovell-Badge R, Masters JR, Meredith J, Stacey GN, Thraves P, Vias M, Cancer Research UK (2014) Guidelines for the use of cell lines in biomedical research. Br J Cancer 111(6):1021\u20131046. https:\/\/doi.org\/10.1038\/bjc.2014.166","journal-title":"Br J Cancer"},{"issue":"10","key":"9867_CR71","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s11626-999-0091-8","volume":"35","author":"WG Dirks","year":"1999","unstructured":"Dirks WG, MacLeod RA, Drexler HG (1999) ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev Biol Anim 35(10):558\u2013559. https:\/\/doi.org\/10.1007\/s11626-999-0091-8","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"9867_CR72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s004410051340","volume":"297","author":"F Kiessling","year":"1999","unstructured":"Kiessling F, Kartenbeck J, Haller C (1999) Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res 297(1):131\u2013140","journal-title":"Cell Tissue Res"},{"issue":"2","key":"9867_CR73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3346\/jkms.2002.17.2.161","volume":"17","author":"JS Park","year":"2002","unstructured":"Park JS, Hong GR, Baek SW, Shin DG, Kim YJ, Shim BS (2002) Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells. J Korean Med Sci 17(2):161\u2013167. https:\/\/doi.org\/10.3346\/jkms.2002.17.2.161","journal-title":"J Korean Med Sci"},{"issue":"8","key":"9867_CR74","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1290\/1071-2690(2001)037<0505:PCOHUV>2.0.CO;2","volume":"37","author":"K Suda","year":"2001","unstructured":"Suda K, Rothen-Rutishauser B, Gunthert M, Wunderli-Allenspach H (2001) Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 37(8):505\u2013514","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"9867_CR75","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/excr.1996.0168","volume":"225","author":"SE Hughes","year":"1996","unstructured":"Hughes SE (1996) Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp Cell Res 225(1):171\u2013185. https:\/\/doi.org\/10.1006\/excr.1996.0168","journal-title":"Exp Cell Res"},{"issue":"2","key":"9867_CR76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1113\/jphysiol.1952.sp004789","volume":"118","author":"AA Miles","year":"1952","unstructured":"Miles AA, Miles EM (1952) Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118(2):228\u2013257. https:\/\/doi.org\/10.1113\/jphysiol.1952.sp004789","journal-title":"J Physiol"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-019-09867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-019-09867-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-019-09867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:25:05Z","timestamp":1667521505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-019-09867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,28]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s10930-019-09867-y","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"type":"print","value":"1572-3887"},{"type":"electronic","value":"1875-8355"}],"subject":[],"published":{"date-parts":[[2019,9,28]]},"assertion":[{"value":"28 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}